A clinical study on latest trends of psoriasis in patients attending dermatology OPD in a tertiary care center
Latest trends in psoriasis
DOI:
https://doi.org/10.66344/jpad.v32i2.1885Keywords:
Psoriasis, dye allergyAbstract
Background Psoriasis is a chronic papulosquamous disorder of skin associated with systemic manifestations. Genetic and environmental factors play a major role in the development of psoriasis. Studies in India reveal a prevalence of 0.44 to 2.8%. Updated data of clinical trends will help in the diagnosis and management.
Methods To calculate hospital-based prevalence and the clinical patterns of psoriasis among patients attending dermatology outpatient department, Kakinada, Andhra Pradesh, India, a descriptive cross-sectional study was designed and conducted for 6 months from October 2020 to March 2021. A total of 430 patients with psoriatic features attended our OPD during this 6 months’ period. Histopathological examination was done for relevant cases.
Results A total 9821 patients attended to the dermatology outpatient department during this period. Out of which 430 patients had psoriasis, so it gives a hospital based prevalence of 4.4%. Out of 430 patients, 58% were males and the disease was most common in 25 -50 years’ age group (53%). Most common clinical pattern observed irrespective of age and sex was chronic plaque psoriasis. Palmoplantar psoriasis (35%) and scalp psoriasis (10.1%) were also common. Obesity, diabetes mellitus, hypertension, dye allergy and detergent allergy were frequently associated with the disease.
Conclusion There is a slight increase in the hospital-based prevalence of psoriasis in our study which may be attributed to the lifestyle changes and comorbidities like obesity, diabetes and hypertension. Increased incidence of allergic contact dermatitis with use of dyes, detergent and cosmetics may be the trigger for scalp and palmoplantar psoriasis
References
1. Gudjonsson JE, Elder JT. Psoriasis: epidemiology. Clin Dermatol. 2007;25:535-46.
2. Glickman FS. Lepra, psora, psoriasis. J Am Acad Dermatol. 1986;14:863-6.
3. Kaur I, Kumar B, Sharma VK, Epidemiology of psoriasis in a clinic from North India. Indian J Dermatol Venereol Leprol. 1986;52(4):208-12.
4. Bedi TR. Psoriasis in North India. Geographical variations. Dermatologica. 1977;155(5):310-4.
5. Swanbeck G, Inerot A, Martinsson T. A population genetic study of psoriasis. Br J Dermatol. 1994;131(1):32-9.
6. Pietrzak A, Chodorowska G, Szepietowski J, Zalewska-Janowska A, Krasowska D, Hercogová J. Psoriasis and serum lipid abnormalities. Dermatol Ther. 2010;23:160-73.
7. Velappan, Ravichandran & Venu, Sridhar & Ramasamy, Sindhuja & Chellappan, Lakshmanan. Current scenario in clinical trends of psoriasis in tertiary care hospital. Int J Res Dermatol. 2019;5(3):452-6.
8. Krueger JG, Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis. 2005;64(Suppl 2): ii30–ii36.
9. Dogra S, Mahajan R. Psoriasis: Epidemiology, clinical features, co-morbidities, and clinical scoring. Indian Dermatol Online J. 2016;7(6):471-80.
10. Griffyhs CE, Christofers E, Barker JN. A Classification of psoriasis vulgaris according to phenotype. Br J Dermatol. 2007;156:258-62.
11. Ghosal A, Gangopadhyay D, Chanda M, Das N. Study of nail changes in psoriasis. Indian J Dermatol. 2004;49:18-21.
12. Alexander E, Pinto J, Pal GS, Kamath N, Kuruvilla M. Disease concomitance in psoriasis: A clinical study of 61 cases. Indian J Dermatol Venereol Leprol. 2001;67:66-8.
13. Basko-Plluska J, Petronic-Rosic V. Psoriasis: epidemiology, natural history, and differential diagnosis. Psoriasis (Auckl). 2012;2:67-76.
https://doi.org/10.2147/PTT.S24009
14. Gisondi P, Tessari G, ContiA PS, Schianchi S, Peserico A, Giannetti A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital based case control study. Br J Dermatol. 2007;157:68–73.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Darsan S, Suruthi Purushothaman, Hasini budeda, S. S. Ravi, V. V. V. Satyanarayana
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
